<DOC>
	<DOC>NCT02439983</DOC>
	<brief_summary>The study is designed to evaluate the effects of the proprietary nutritional supplement on cognition, mood, and brain imaging parameters following a relatively short period of treatment.</brief_summary>
	<brief_title>Brain Imaging Study</brief_title>
	<detailed_description />
	<criteria>Both male and female subjects will be included. Age between 4060 years inclusive. Healthy subjects who, in the opinion of the investigator, are free of any medical conditions that might affect study measures. Eats 1 or fewer servings of fatty fish per week. BMI &lt; 35 Current or past neurological illness. Substance abuse or dependence within the prior 60 days. Current depression (HAMD greater than 20) or anxiety disorder (HAMA greater than 18). Current or past history of psychiatric disorder. History of head trauma with loss of consciousness. Contraindication to brain MRI examination. Supplementation with Omega 3, fish oil, or other over the counter supplements including the other bioactive ingredients in the proprietary nutritional supplement, antioxidants and multivitamin mineral supplements for the previous 3 months. Plasma Omega3 Index &gt;5% at screening visit. Subject has a known allergy or intolerance to any of the ingredients contained in the proprietary nutritional supplement or placebo. Subject is currently pregnant, planning to become pregnant, or is breastfeeding.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>